Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Sep 08, 2017

Mylan Statement on Warning Letter Issued to Pfizer’s EpiPen® Auto-Injector Manufacturing Site

Aug 24, 2017

Otsuka and Mylan Announce License Agreement to Commercialize Delamanid (Deltyba™) for Multidrug-Resistant Tuberculosis (MDR-TB) in High-Burden Countries

Aug 17, 2017

Mylan Finalizes Settlement Agreement on Medicaid Rebate Classification for EpiPen® Auto-Injector

Aug 10, 2017

Mylan Advances Access in the Fight Against HIV with the Launch of Three Generic Antiretroviral Medicines in Canada

Aug 09, 2017

Mylan Reports Second Quarter 2017 Results and Updates 2017 Guidance

Aug 08, 2017

Mylan Launches Avonza™ in India

Aug 07, 2017

Mylan Receives Tentative Approval for "TLD" Under PEPFAR

Jul 27, 2017

Mylan Launches MyHep All™ in India

Jul 26, 2017

Mylan Receives WHO Prequalification for Generic Sovaldi®

Jul 19, 2017

Theravance Biopharma and Mylan Announce Positive Results from 12-Month Phase 3 Safety Study of Revefenacin (TD-4208) in Patients with Chronic Obstructive Pulmonary Disease (COPD)

Pagination

First page
Previous page
…
Page 16
Page 17
Page 18
Page 19
Current page 20
Page 21
Page 22
Page 23
Page 24
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2025 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.